Juliana Maynard is an expert Imaging Scientist specialising in pre-clinical imaging technologies, which ultimately aims to advance innovative drug discovery, bringing medicines to patients, faster.
An enthusiastic, proactive, very committed and hard-working individual Juliana has worked with a broad range of imaging modalities including PET, SPECT, CT, ultrasound and MRI. She has a proven track record of research for over 15 years as evidenced in her publications across a wide range of disease and therapy areas. She possesses good project management skills and has successfully delivered multiple projects with a strong delivery focus. She enjoys working across boundaries using her interpersonal skills to engage with customers and to “put an idea” into practice
Juliana has been based in the North West since earning her PhD at the University of Edinburgh in 2006. She worked at the University of Manchester and then spent 9 years in increasingly senior roles at AstraZeneca. On leaving AstraZeneca, Juliana recognised the opportunity that medical imaging can have in improving and accelerating drug discovery and set up the creation of a commercial imaging service offering with the ambition to make this readily available for use across the UK drug discovery community.